Literature DB >> 23812565

Community-acquired urinary tract infection: age and gender-dependent etiology.

Denise Swei Lo1, Huei Hsin Shieh, Selma Lopes Betta Ragazzi, Vera Hermina Kalika Koch, Marina Baquerizo Martinez, Alfredo Elias Gilio.   

Abstract

INTRODUCTION: Choosing the antimicrobial agent for initial therapy of urinary tract infection (UTI) is usually empirical and should consider the prevalence of uropathogens in different age groups and gender.
OBJECTIVE: To establish prevalence rates of uropathogens in community-acquired UTI in relation to age and gender.
METHODS: Cross-sectional study conducted in the emergency department (ED) of a general hospital, from January to December, 2010, in patients younger than 15 years old who had clinical suspicion of UTI and collected quantitative urine culture. UTI was defined as urine culture with growth of a single agent > 100.000 colony forming units (cfu)/mL in a midstream collection or ≥ 50.000 cfu/mL in urethral catheterization.
RESULTS: There were 63.464 visits to ED. 2577 urine cultures were obtained, of whom 291 were positive for UTI (prevalence = 11.3% of clinical suspicion and 0.46% of visits), 212 cases (72.8%) in females, median age = 2.6 years. The predominant uropathogen was E. coli (76.6%), followed by Proteus mirabilis (10.3%) and Staphylococcus saprophyticus (4.1%). Among infants < 3 months, prevalence rates of E. coli were significantly lower (50% vs 78.4%; OR = 0.276; p = 0.006). Higher prevalences of Staphylococcus saprophyticus occurred among patients > 10 years (24.4% vs 0.4%; OR = 79.265; p < 0.0001). Proteus mirabilis was significantly more prevalent in boys than girls (24.0% vs 5.2%; OR = 5.786; p < 0.001).
CONCLUSIONS: E. coli was the most prevalent community-acquired uropathogen. Nevertheless, initial empiric antimicrobial treatment of UTI should consider the significant prevalence of other agents different from E. coli in infants < 3 months, the high prevalence of Staphylococcus saprophyticus in patients > 10 years and Proteus mirabilis in males.

Entities:  

Mesh:

Year:  2013        PMID: 23812565     DOI: 10.5935/0101-2800.20130016

Source DB:  PubMed          Journal:  J Bras Nefrol        ISSN: 0101-2800


  14 in total

Review 1.  Diagnosis of Urinary Tract Infections in Children.

Authors:  Christopher D Doern; Susan E Richardson
Journal:  J Clin Microbiol       Date:  2016-04-06       Impact factor: 5.948

2.  Evaluation of BacterioScan 216Dx in Comparison to Urinalysis as a Screening Tool for Diagnosis of Urinary Tract Infections in Children.

Authors:  Ferdaus Hassan; Heather Bushnell; Connie Taggart; Caitlin Gibbs; Steve Hiraki; Ashley Formanek; Megan Gripka; Rangaraj Selvarangan
Journal:  J Clin Microbiol       Date:  2019-08-26       Impact factor: 5.948

Review 3.  Urinary tract infections in the infant.

Authors:  Mehreen Arshad; Patrick C Seed
Journal:  Clin Perinatol       Date:  2014-12-24       Impact factor: 3.430

4.  The distribution of disease in the Republic of Suriname - A pharmacoepidemiological analysis using the claims database of the State Health Foundation of the year 2017.

Authors:  Vinoj H Sewberath Misser; Arti Shankar; Ashna Hindori-Mohangoo; Jeffrey Wickliffe; Maureen Lichtveld; Dennis R A Mans
Journal:  J Public Health Epidemiol       Date:  2021-11-30

5.  Prevalence and phenotypic characterization of Enterococcus species isolated from clinical samples of pediatric patients in Jimma University Specialized Hospital, south west Ethiopia.

Authors:  Biruk Yeshitila; Milkiyas Toru; Getnet Beyene; Tesfaye Kassa; Zeleke Gizachew; Rawleigh Howe
Journal:  BMC Res Notes       Date:  2018-05-08

6.  Staphylococcus haemolyticus epididymo-orchitis and bacteraemia: a case report.

Authors:  Christina Pindar; Roberto A Viau
Journal:  JMM Case Rep       Date:  2018-07-05

7.  Community-acquired methicillin-resistant Staphylococcus epidermidis pyelonephritis in a child: a case report.

Authors:  Hiroaki Kanai; Hiroki Sato; Yoshichika Takei
Journal:  J Med Case Rep       Date:  2014-12-09

8.  High prevalence of multidrug-resistance uropathogenic Escherichia coli strains, Isfahan, Iran.

Authors:  Razieh Dehbanipour; Sedighe Rastaghi; Mansour Sedighi; Nafiseh Maleki; Jamshid Faghri
Journal:  J Nat Sci Biol Med       Date:  2016 Jan-Jun

9.  In Vitro Activity of Oral Antimicrobial Agents against Pathogens Associated with Community-Acquired Upper Respiratory Tract and Urinary Tract Infections: A Five Country Surveillance Study.

Authors:  Douglas J Biedenbach; Robert E Badal; Ming-Yi Huang; Mary Motyl; Puneet K Singhal; Roman S Kozlov; Arthur Dessi Roman; Stephen Marcella
Journal:  Infect Dis Ther       Date:  2016-06-10

10.  Effects of age and gender on reference levels of biomarkers comprising the pediatric Renal Activity Index for Lupus Nephritis (p-RAIL).

Authors:  Michael R Bennett; Qing Ma; Jun Ying; Prasad Devarajan; Hermine Brunner
Journal:  Pediatr Rheumatol Online J       Date:  2017-10-13       Impact factor: 3.054

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.